Brief Report: A phase IIa, randomized, double-blind, placebo-controlled trial of apilimod mesylate, an interleukin-12/interleukin-23 inhibitor, in patients with rheumatoid arthriti... von Krausz, Sarah, Boumans, Maria J. H., Gerlag, Danielle M., Lufkin, Joelle, van Kuijk, Arno W. R., Bakker, Alian, de Boer, Maarten, Lodde, Beatrijs M., Reedquist, Kris A., Jacobson, Eric W., O'Meara, Michael, Tak, Paul P.

Volltext

A Phase IIa, Randomized, Double-Blind, Placebo-Controlled Trial of Apilimod Mesylate, an Interleukin-12/Interleukin-23 Inhibitor, in Patients With Rheumatoid Arthritis von KRAUSZ, Sarah, BOUMANS, Maria J. H, O'MEARA, Michael, TAK, Paul P, GERLAG, Danielle M, LUFKIN, Joelle, KUIJK, Arno W. R. Van, BAKKER, Alian, DE BOER, Maarten, LODDE, Beatrijs M, REEDQUIST, Kris A, JACOBSON, Eric W

Volltext